22840-2439 NDC - BLACK LOCUST BLOSSOM (ROBINIA PSEUDOACACIA)

Drug Information

  • Product NDC: 22840-2439
  • Proprietary Name: Black Locust Blossom
  • Non Proprietary Name: Robinia pseudoacacia
  • Active Ingredient(s): .1 g/mL ROBINIA PSEUDOACACIA POLLEN
  • Administration Route(s): INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS
  • Dosage Form(s): SOLUTION
  • Pharmacy Class(es): Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]

Labeler Information

Field Name Field Value
Labeler Name: Greer Laboratories, Inc.
Product Type: NON-STANDARDIZED ALLERGENIC
FDA Application Number: BLA101833
Marketing Category: BLA
Start Marketing Date:9/15/1981

Package Information

No. Package Code Package Description Billing Unit
122840-2439-210 mL in 1 VIAL, MULTI-DOSE (22840-2439-2)
222840-2439-450 mL in 1 VIAL, MULTI-DOSE (22840-2439-4)

NDC Record

Field Name Field Value Definition
PRODUCT NDC22840-2439 
PRODUCT TYPE NAMENON-STANDARDIZED ALLERGENICIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEBlack Locust BlossomThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMERobinia pseudoacaciaThis is the date that the labeler indicates was the start of its marketing of the drug product.
DOSAGE FORM NAMESOLUTIONThis is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
ROUTE NAMEINTRADERMAL; PERCUTANEOUS; SUBCUTANEOUSThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE9/15/1981This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
MARKETING CATEGORY NAMEBLAName of Company corresponding to the labeler code segment of the Product NDC.
APPLICATION NUMBERBLA101833This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEGreer Laboratories, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEROBINIA PSEUDOACACIA POLLENAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH.1 
ACTIVE INGRED UNITg/mL 
PHARM CLASSESAllergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/19/2025